| Exploring newer target sodium glucose transporter 2 for the treatment of diabetes mellitus. | |
| | |
MedLine Citation:
|
PMID: 21034414 Owner: NLM Status: In-Process |
Abstract/OtherAbstract:
|
Diabetes mellitus is an independent risk factor for the development of coronary artery disease, myocardial infarction, hypertension, and dyslipidemia. The treatment of diabetes has been mainly focused on maintaining normal blood glucose concentrations. Insulin and hypoglycemic agents have been used as standard therapeutic strategies. However, these are characterized by limited efficacy and adverse side effects, making the development of new therapeutic alternatives mandatory. Inhibition of glucose reabsorption in the kidney, mediated by Sodium Glucose Transporters (SGLT's), represents a promising therapeutic approach. The high-affinity sodium glucose cotransporter (SGLT1) is expressed to some extent in the kidney and contributes to glucose reabsorption, However Genetic mutations in the SGLT1 gene leading to a functional defect are responsible for glucose/galactose malabsorption. The low-affinity sodium glucose cotransporter (SGLT2), which is expressed specifically in the kidney, plays a major role in renal glucose reabsorption in the proximal tubule. We focused on SGLT2 as a molecular target for this review because it plays a major role in renal glucose reabsorption, and its tissue distribution is limited in the kidney to reduce the likelihood for mechanism-based side effects. Phlorizin, a natural phenolic O-glucoside has been known to induce glucosuria for more than 100 years. As it is not a specific SGLT inhibitor, later on o-glucoside is replaced by c-glycoside as it is resistant to hydrolysis by β-glucosidases. The present review summarizes the concept of SGLT2 selective target based therapy for diabetes mellitus and the current clinical and preclinical development of SGLT2 inhibitors. |
| | |
Authors:
|
H B Vaidya; R K Goyal |
Related Documents
:
|
19646954 - Effects of ketamine on glucose uptake by glucose transporter type 3 expressed in xenopu... 157804 - Effects of estrogen to alter amino acid transport in r3230ac mammary carcinomas and its... 8403984 - Yeast sugar transporters. 8770034 - Effect of glucose on uptake of radiolabeled glucose, 2-dg, and 3-o-mg by the perfused r... 3258834 - Proteinuria and activated t-lymphocytes in diabetic nephropathy. 3304974 - Biphasic insulin release as the expression of combined inhibitory and potentiating effe... |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Mini reviews in medicinal chemistry Volume: 10 ISSN: 1875-5607 ISO Abbreviation: Mini Rev Med Chem Publication Date: 2010 Sep |
Date Detail:
|
Created Date: 2010-11-01 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101094212 Medline TA: Mini Rev Med Chem Country: Netherlands |
Other Details:
|
Languages: eng Pagination: 905-13 Citation Subset: IM |
Affiliation:
|
Department of Pharmacology, L.M. College of Pharmacy, Navrangpura, Ahmedabad-380009, Gujarat, India. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Antimalarial drugs and their useful therapeutic lives: rational drug design lessons from pleiotropic...
Next Document: New strategies and patent therapeutics in EBV-associated diseases.